161 related articles for article (PubMed ID: 8028071)
1. Epstein-Barr virus and nasopharyngeal carcinoma: bringing molecular genetics strategies to head and neck oncology.
Freeman JL; McIvor NP; Feinmesser R; Cheung RK; Dosch HM
J Otolaryngol; 1994 Apr; 23(2):130-4. PubMed ID: 8028071
[TBL] [Abstract][Full Text] [Related]
2. Determination of nonendemic nasopharyngeal carcinoma by in situ hybridization for Epstein-Barr virus EBER1 RNA: sensitivity and specificity in cervical node metastases.
Dictor M; Sivén M; Tennvall J; Rambech E
Laryngoscope; 1995 Apr; 105(4 Pt 1):407-12. PubMed ID: 7536285
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus detection in neck metastases by polymerase chain reaction.
Walter MA; Menarguez-Palanca J; Peiper SC
Laryngoscope; 1992 May; 102(5):481-5. PubMed ID: 1315410
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability in Epstein-Barr virus associated with nasopharyngeal carcinoma.
Tanunyutthawongese C; Sriuranpong V; Kerekhanjanarong V; Changchup B; Yenrudi S; Supiyaphun P; Voravud N; Mutirangura A
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S71-7. PubMed ID: 9071070
[TBL] [Abstract][Full Text] [Related]
6. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
7. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
Niedobitek G; Agathanggelou A; Nicholls JM
Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
[TBL] [Abstract][Full Text] [Related]
9. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity for chromosome 11 in Epstein-Barr-virus associated nasopharyngeal carcinoma.
Mutirangura A; Tanunyutthawongese C; Kerekhanjanarong V; Sriuranpong V; Pornthanakasem W; Yenrudi S; Supiyaphun P; Voravud N
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S65-70. PubMed ID: 9071069
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
Tan EL; Looi LM; Sam CK
Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
[TBL] [Abstract][Full Text] [Related]
13. Detection of Epstein-Barr virus DNA and HHV-6 DNA in tissue biopsies from patients with nasopharyngeal carcinoma by polymerase chain reaction.
Kositanont U; Kondo K; Chongkolwatana C; Metheetrairut C; Puthavathana P; Chantarakul N; Wasi C; Yamanishi K
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):455-60. PubMed ID: 8160052
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF
Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
[TBL] [Abstract][Full Text] [Related]
15. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
Sun N; Chen X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
Tsai ST; Jin YT; Mann RB; Ambinder RF
Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and nasopharyngeal carcinoma.
Raab-Traub N
Semin Cancer Biol; 1992 Oct; 3(5):297-307. PubMed ID: 1335793
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
